Neuland Laboratories Ltd Sustainability Reports

Neuland Laboratories Limited is an India-based contract development and manufacturing organization (CDMO) that produces active pharmaceutical ingredients (APIs). The company provides end-to-end chemistry solutions including small molecule synthesis, advanced intermediates, and peptide manufacturing for the global pharmaceutical industry.

Sector: Manufacturing

Country: India

Exchange: Bombay Stock Exchange

LEI: 335800AVHZURTYQ17N08

FIGI: BBG001S8DXL9

20 reports from 2016 to 2026

• Neuland Laboratories Ltd 2026 Integrated Annual Report
• Neuland Laboratories Ltd 2025 Task Force on Climate-Related Financial Disclosures (TCFD) Report
• Neuland Laboratories Ltd 2025 Biodiversity Impact Assessment Report
• Neuland Laboratories Ltd 2025 The Neuland Promise Integrated Report
• Neuland Laboratories Ltd 2024 Supplementary ESG Data Book